296 related articles for article (PubMed ID: 23847759)
21. The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia.
Algeri M; Merli P; Locatelli F; Pagliara D
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501237
[TBL] [Abstract][Full Text] [Related]
22. A Review of CAR-T Therapy in Pediatric and Young Adult B-Lineage Acute Leukemia: Clinical Perspectives in Singapore.
Seng MS; Meierhofer AC; Lim FL; Soh SY; Hwang WYK
Onco Targets Ther; 2023; 16():165-176. PubMed ID: 36941828
[TBL] [Abstract][Full Text] [Related]
23. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
24. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.
August KJ; Narendran A; Neville KA
Drugs; 2013 Apr; 73(5):439-61. PubMed ID: 23568274
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
26. An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia.
Patel J; Gao X; Wang H
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108359
[TBL] [Abstract][Full Text] [Related]
27. Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.
Shah NN; Loeb DM; Khuu H; Stroncek D; Ariyo T; Raffeld M; Delbrook C; Mackall CL; Wayne AS; Fry TJ
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2149-2154. PubMed ID: 27634018
[TBL] [Abstract][Full Text] [Related]
28. [Roles of Tumor Infiltrating Lymphocytes in Hematologic Malignancies-Review].
Liang M; Zhang H; Chen FX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1241-7. PubMed ID: 27531808
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy and Allogeneic Bone Marrow Transplantation in B Acute Lymphoblastic Leukemia: How to Sequence?
Komitopoulou A; Baltadakis I; Peristeri I; Goussetis E
Clin Hematol Int; 2022 Jun; 4(1-2):11-20. PubMed ID: 35950202
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
31. T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development.
Thomas X
Expert Opin Investig Drugs; 2023 Jan; 32(1):37-52. PubMed ID: 36541671
[TBL] [Abstract][Full Text] [Related]
32. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.
Tsirigotis P; Shimoni A; Nagler A
Ann Med; 2014 Sep; 46(6):384-96. PubMed ID: 24888385
[TBL] [Abstract][Full Text] [Related]
33. Current Status of CAR T Cell Therapy for Leukemias.
Harris K; LaBelle JL; Bishop MR
Curr Treat Options Oncol; 2021 Jun; 22(7):62. PubMed ID: 34097135
[TBL] [Abstract][Full Text] [Related]
34. Current status of CAR-T cell therapy for pediatric hematologic malignancies.
Hiramatsu H
Int J Clin Oncol; 2023 Jun; 28(6):729-735. PubMed ID: 37154980
[TBL] [Abstract][Full Text] [Related]
35. Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.
Shalabi H; Angiolillo A; Fry TJ
Front Pediatr; 2015; 3():80. PubMed ID: 26484338
[TBL] [Abstract][Full Text] [Related]
36. Novel Therapies in Acute Lymphoblastic Leukemia.
Phelan KW; Advani AS
Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and treatment of pediatric acute lymphoblastic leukemia.
Lee JW; Cho B
Korean J Pediatr; 2017 May; 60(5):129-137. PubMed ID: 28592975
[TBL] [Abstract][Full Text] [Related]
38. Immune-based therapeutics for pediatric cancer.
Capitini CM; Mackall CL; Wayne AS
Expert Opin Biol Ther; 2010 Feb; 10(2):163-78. PubMed ID: 19947897
[TBL] [Abstract][Full Text] [Related]
39. How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
Zhang M; Huang H
Front Immunol; 2020; 11():611710. PubMed ID: 33384696
[TBL] [Abstract][Full Text] [Related]
40. Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study.
Wang S; Liu A; Wang N; Wang Y; Zhang A; Wang L; Yu W; Li C; Zhang Y; Hu Q
Front Pediatr; 2022; 10():1100404. PubMed ID: 36727001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
